Multi-modal profiling of single cells represents one of the latest technological advancements in 11 molecular biology. Among various single-cell multi-modal strategies, cellular indexing of transcriptomes 12 and epitopes by sequencing (CITE-seq) allows simultaneous quantification of two distinct species: RNA 13 and surface marker proteins (ADT). Here, we introduce CiteFuse, a streamlined package consisting of 14 a suite of tools for pre-processing, modality integration, clustering, differential RNA and ADT expression 15 analysis, ADT evaluation, ligand-receptor interaction analysis, and interactive web-based visualization 16 of CITE-seq data. We show the capacity of CiteFuse to integrate the two data modalities and its relative 17 advantage against data generated from single modality profiling. Furthermore, we illustrate the pre-18 processing steps in CiteFuse and in particular a novel doublet detection method based on a combined 19 index of cell hashing and transcriptome data. Collectively, we demonstrate the utility and effectiveness 20 of CiteFuse for the integrative analysis of transcriptome and epitope profiles from CITE-seq data. 22 ligand-receptor interaction 23 53 (http://shiny.maths.usyd.edu.au/CiteFuse/), allowing users to upload and analyse their CITE-seq 54 datasets. 55 Results 56 CiteFuse gains information from multi-modal integration of CITE-seq data 57 To take advantage of the complementary information present in multi-modal CITE-seq data, CiteFuse 58 integrates mRNA and ADT expression by constructing networks across single cells for each data 59 modality and fusing these networks using a similarity network fusion algorithm (Wang et al., 2014) 60 (Figure 1A, blue tile). It subsequently uses a spectral clustering algorithm to cluster the cells based on 61 the fused matrix. To test whether there is any advantage in using the fused multi-modal expression 62 matrix over the single-modal matrices, we performed a comparison between the different modalities 63 and across existing clustering algorithms with simulated CITE-seq data (Zhang et al., 2019) (Figure 64 S1A). We demonstrate that in both "easy" and "hard" scenarios (see Methods), CiteFuse clusters cells 65 more accurately than directly applying spectral clustering on the two single-modal data types (Figure 66 S1B). Moreover, we demonstrate that CiteFuse performs better compared to several established 67 clustering procedures, including SIMLR (Wang et al., 2017), PCA + k-means, and Seurat (Satija et al., 68 2015) with either RNA or ADT expression matrix (Figure S1B).
Introduction 24
The latest advancement in multi-modal profiling of single cells promises to revolutionise our 25 understanding in cellular biology that was previously inconceivable through bulk profiling technologies 26 (Datlinger et al., 2017; Macaulay et al., 2015; Mohammed et al., 2017) . Among various single-cell multi-27 modal strategies, cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) (Stoeckius 28 et al., 2017) and its variants such as RNA expression and protein sequencing (REAP-seq) (Peterson and its advantage over analysing each individual source and modality of data. CiteFuse represents the 48 first method specifically designed to systematically integrate RNA and ADT modalities of single cells in 49 CITE-seq data. We anticipate its increasing utility given the rapidly accumulating volume of multi-omic 50 and multi-modality single cell data generated using CITE-seq from various biological studies (Mimitou 51 et al., 2019; Stoeckius et al., 2017) . Finally, CiteFuse is implemented as an R package (http://SydneyBioX.github.io/CiteFuse/) as well as a user-friendly web application represent outlier cells that have both high total UMIs and high HTO expression ( Figure S3C) . We show 110 that our approach captures most doublets detected through HTODemux and Scrublet but also identifies 111 additional ones that may have been missed by HTODemux and Scrublet (Figure S3D) . When we 112 quantified the total UMIs and number of unique genes in cells exclusively identified by each method 113 ( Figure S3E) , we found that doublets exclusively detected by HTODemux and Scrublet show 114 characteristics that resemble singlets whereas those only detected by CiteFuse resemble doublets 115 (Figures S3B and S3E ).
116
Strikingly, we observed the most improved separation of clusters on the first two principal components 117 of HTO expression before and after filtering of doublets detected by CiteFuse (Figure 2C ), suggesting 118 our CiteFuse pipeline enables more accurate filtering of both within-and cross-sample doublets when
119
HTO libraries are available.
120

CiteFuse doublet filtering preserves the separation between T-cell subpopulations
121
To evaluate the impact of filtering method on the downstream analysis, we applied CiteFuse clustering 122 on data either unfiltered (4292 cells) or filtered using the different doublet detection methods-
123
HTODemux (3753 cells), Scrublet (3968 cells), and CiteFuse (3612 cells). Visualisation of the clusters 124 on UMAP revealed very different clustering outcomes by each filtering method, revealing that filtering 125 method can have a large impact on downstream analysis (Figure S4A ).
126
We demonstrate the impact of filtering method on downstream analysis by evaluating the capacity of 127 the unfiltered and filtered datasets to define CD4+ and CD8+ T-cell types, two major groups of T The selection of a set of ADTs for CITE-seq may be an expensive process, requiring in many cases Figure S5B ). For example, in the PBMC CITE-seq dataset, we 143 found that CD223 and IgG1 are the two ADTs receiving the lowest importance scores and therefore 144 may not provide much additional information for cell type clustering. Indeed, we observed minimum 145 changes in the clustering outcome (ARI=0.99) even without the two ADTs ( Figure S5C ). We find that 146 more ADTs can be excluded (Subsets 2-3) with minimal effect on clustering results. In addition to ADT 147 evaluation, CiteFuse can also perform cluster-specific differential gene expression analysis to detect 148 and compare differentially expressed RNA and ADT (Figure 2E ) and generate visualisation of ADT-
149
RNA correlation networks unique to each cluster, allowing users to evaluate relationships between ADT 150 and RNA in an intra-cluster manner (Figure 2F ). Figures 2G and S6A) . We compared the ligand-161 receptor interactions identified by CiteFuse with those identified from the conventional approach where 162 the expression of RNA alone is used as a readout for both ligand and receptor expression ( Figure S6A ).
163
We found that the overlap in interactions between the conventional approach and CiteFuse was variable 164 across clusters, but generally a large portion of the ligand-receptor interactions identified through the conventional approach (referred to as RNA-specific) were not identified as interactions through 166 CiteFuse (Figure S6B ). We also observed in each cluster a fraction of interactions that were identified 167 only by CiteFuse (referred to as CiteFuse-specific) ( Figure S6B ).
168
We then hypothesised that the large proportion of interactions in the conventional approach that are not 169 detected by CiteFuse may be because of false positive predictions. To investigate this, we calculated 170 the normalised log expression of the ADT and mRNA of all receptors that were identified in a ligand-171 receptor interaction for each category (CiteFuse-specific, RNA-specific, and Common). We found that 172 although the mRNA expression of the receptors was comparable between the categories the ADT 173 expression of these receptors was much lower in the RNA-specific group than the other two groups 174 ( Figure S6C) . Notably, we found that a strong positive correlation of ADT and mRNA expression
175
(ranked relative to each cluster; see Methods) for receptors identified in a ligand-receptor interaction in 176 the Common and CiteFuse-specific categories but no correlation for those in the RNA-specific category
177
( Figure S6D) . Similarly, we show that the mRNA expression of ligands detected in the RNA-specific 178 category have higher rankings than those detected in the other two categories (Figure S6E) . These 
202
For each simulation, we generated a dataset of 500 single cells among which were six cell types where 203 total numbers of RNA and ADT were 10,000 and 100, respectively. The following parameter settings 204 for sigma (s), which controls within-population variability, and minimum population size (min_pop) were 205 used to simulate CITE-seq data of different levels of difficulty. 
218
CITE-seq data from healthy human PBMCs
219
To demonstrate our method, we used the recently published CITE-seq data (Mimitou et al., 2019) .
220
Specifically, we used the ECCITE-seq dataset from PBMC samples isolated from the blood of healthy 
224
Calculation of signature scores for T-cell subpopulations
225
To calculate the signature scores for the various immune populations, we averaged the expression of 226 the following sets of genes that were previously defined as marker genes for the respective cell types 227 of interest:
228
(1) S100A4, CRIP1, and AHNAK were used to define memory CD4+ CiteFuse implements a stepwise procedure to identify both the cross-sample doublets and within-236 sample doublets from CITE-seq data when cell hashing data is available.
237
(1) Cross-sample doublet identification 238 First, we fit a two-component Gaussian mixture model to each log-transformed HTO expression.
239
The intersection point defined from the mixture model is used to categorise each cell in terms 240 of whether the HTO is either highly or lowly expressed. The cells found to have a single highly 241 expressed HTO are considered as singlets whilst those that have two or more highly expressed
242
HTOs are considered as doublets or multiplets. Cells without any highly expressed HTOs are 243 considered as empty droplets.
244
( 2) For the selection of RNA and ADT markers for a given cluster, we considered the following three criteria:
276
(1) An adjusted P-value of lower than 0.05;
277
(2) The mean expression of RNA and ADT in the cells of the cluster is greater than the mean 278 expression of RNA and ADT in cells of all other clusters; and
279
(3) The proportion of cells in the cluster expressing the RNA and ADT is greater than the proportion 280 of cells expressing the RNA and ADT across all other clusters by at least 10%.
281
CiteFuse enables two exploration methods to visualise the results of differential expression analysis for 282 both RNA and ADT in a single plot:
283
(1) DEcomparisonPlot
284
The DEcomparisonPlot visualises the positive log10 transformed adjusted P-values as a dot of 285 the RNA and the negative log10 transformed adjusted p-values of its corresponding ADT signal 286 on the same y-axis.
287
(2) DEbubblePlot
288
We used the circlepack plot to visualise the RNA and ADT markers, where each marker is 289 represented by a circle and the size of the circle represents the magnitude of the negative log10 
300
Evaluation of ADT importance
To evaluate the importance for each ADT towards the clustering outcome, we trained a random forest 302 model on a subset of randomly sampled cells (80% of total), using the clustering labels from the 303 similarity network fusion of the PBMC CITE-seq data. After 50 repeated fitting of the random forest 304 model, we quantified the feature importance in terms of the mean decrease in Gini index as a surrogate 305 of the importance of each ADT towards clustering outcome. We defined ADT importance score as the 306 median of the feature importance of all runs. A higher score indicates greater importance of the ADT.
307
Next, to identify potentially redundant ADTs that do not contribute significantly towards clustering 308 outcome, we sorted the ADTs by importance and drew cut-offs in accordance to the local maximums 309 of the difference in importance scores. We then retained the subset of ADTs the with importance scores 310 greater than the cut-offs and performed similarity network fusion analysis. We calculated the adjusted 311 rand index (ARI) to measure the concordance in clustering outcome for each subset of ADTs against 312 that of the full dataset.
313
Ligand-receptor interaction prediction
314
One of the key challenges in analysing ligand-receptor relationships between two modalities is the 315 difference in scaling and distribution. To address this, we first scaled each feature into a range of 0 to .
319
Another challenge we encountered was the difference in distribution between the two modalities: we 320 observed that the distribution of mRNA expression tends to be more zero-inflated than ADT expression.
321
Because comparing unequal distributions has the potential to introduce bias, especially during ligand- For the analysis of the ligand-receptor interactions identified through CiteFuse and the conventional 335 approach using only mRNA expression, we calculated the concordance of mRNA and ADT expression 336 of receptors. Because the same gene may be predicted to be involved as a receptor in a ligand-receptor 337 interaction in multiple clusters, we performed a cluster-specific analysis as the expression and 338 correlation of the mRNA and ADT of the receptor is likely to be different between clusters. Therefore,
339
we evaluated concordance between mRNA and ADT in a cluster-specific and relative manner by 340 calculating the ranking of mRNA and ADT expression in the cluster of interest in relation to all other 341 clusters. We then plotted the relative ranking of mRNA and ADT expression against one another. For 342 ligands, we also calculated a cluster-specific ranking based on their mRNA expression. 
